ON PURIFICATION OF PROTHROMBIN COMPLEX CONCENTRATES

被引:0
作者
Iserkapov [1 ,2 ]
Berkovsky, A. L. [2 ]
Sergeeva, E., V [2 ]
Dereza, T. L. [2 ]
Kutyurova, O. G. [2 ]
Golubev, E. M. [2 ]
Shvets, V., I [1 ]
机构
[1] MV Lomonosov Moscow State Univ Fine Chem Technol, Moscow, Russia
[2] Minist Publ Hlth Russia, Hematol Res Ctr, Moscow, Russia
来源
GEMATOLOGIYA I TRANSFUZIOLOGIYA | 2014年 / 59卷 / 03期
关键词
prothrombin complex concentrates; indirect anticoagulants; factor VIII bypass activity; hemophilia A; virus safety; chromatography; REVERSAL;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Virus inactivation in activated and total (non-activated) prothrombin complex concentrates by the solvent/detergent method and the stages of their additional purification by anion exchange column chromatography were studied. Conditions were selected for virus inactivation with high output of the target activities. Chromatoghraphic purification effectively removed the solvent/detergent, part of minor proteins, and thrombin generated during activation of the prothrombin complex. The results may serve the base for improving the virus safety of concentrated activated and total prothrombin complexes.
引用
收藏
页码:22 / 29
页数:8
相关论文
共 17 条
  • [1] Ananieva N. M., 2005, GEMATOLOGIYA TRANSFU, V6, P21
  • [2] Bertolini J., 2012, Production of Plasma Proteins for Therapeutic Use
  • [3] BULANOV AY, 2013, TOLYATTINSKIY MED KO, V3, P25
  • [4] Nanofiltration of plasma-derived biopharmaceutical products
    Burnouf, T
    Radosevich, M
    [J]. HAEMOPHILIA, 2003, 9 (01) : 24 - 37
  • [5] Ensuring the biologic safety of plasma-derived therapeutic proteins - Detection, inactivation, and removal of pathogens
    Cai, K
    Gierman, TM
    Hotta, J
    Stenland, CJ
    Lee, DC
    Pifat, DY
    Petteway, SR
    [J]. BIODRUGS, 2005, 19 (02) : 79 - 96
  • [6] Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate A Randomized, Placebo-Controlled, Crossover Study in Healthy Subjects
    Eerenberg, Elise S.
    Kamphuisen, Pieter W.
    Sijpkens, Meertien K.
    Meijers, Joost C.
    Buller, Harry R.
    Levi, Marcel
    [J]. CIRCULATION, 2011, 124 (14) : 1573 - 1579
  • [7] Hemophilia A in the third millennium
    Franchini, Massimo
    Mannucci, Pier Mannuccio
    [J]. BLOOD REVIEWS, 2013, 27 (04) : 179 - 184
  • [8] Gumulec J, 2009, Vnitr Lek, V55, P277
  • [9] Biochemical comparison of seven commercially available prothrombin complex concentrates
    Kalina, U.
    Bickhard, H.
    Schulte, S.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 (10) : 1614 - 1622
  • [10] Kozlov A. A., 2011, LAB DIAGNOSIS HEMOST